+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By End Use (Hospitals, Specialty Clinics), By Delivery Mode (Cloud-based, On-Premise), And Segment Forecasts, 2018 - 2025

  • ID: 4751792
  • Report
  • 105 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • EyePACS, LLC
  • ScImage, Inc.
  • Sonomed Escalon
  • Topcon Corporation
  • VersaSuite
  • MORE
The global ophthalmology PACS market size is expected to reach USD 170.96 million by 2025. It is projected to witness a CAGR of 6.5% during the forecast period and is driven by rising adoption of Electronic Health Record (EHR) and Electronic Medical Records (EMR) solutions globally. Moreover, rising prevalence of eye diseases, such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy, is expected to fuel demand for ophthalmology PACS in near future. The Department of Ophthalmology of National University of Singapore conducted a study in collaboration with National University Health System, Singapore and South Central Asia. According to this study, the number of glaucoma cases diagnosed in 2013 was 17.06 million, which is anticipated to reach around 32.9 million by 2040.

Product development, geographical expansion and M&A are some sustainability strategies adopted by major companies in this market. For instance, in August 2017, Carl Zeiss Meditec Inc., acquired Veracity Innovations, LLC, a U.S.-based medical software company that delivers cloud-based platforms to maximize clinical performance and work efficiency. These platforms help ophthalmologists in delivering personalized technology-enabled care to their patients. The acquisition is intended to expand the former company’s eye care-based digital solutions portfolio. The company is also focusing on expanding the business in Asia Pacific owing to larger patient pool in this region.

Further key findings from the study suggest:
  • Increasing cases of ophthalmic diseases, lack of skilled ophthalmologists, and growing usage of teleophthalmology solutions in developed countries are the factors driving the market
  • According to BrightFocus Foundation’s survey, prevalence of Age-related Macular Degeneration (AMD) is anticipated to rise up to 22 million by 2040. This is also likely to boost market growth
  • Cloud-based PACS is anticipated to register lucrative growth during the forecast period owing to features, such as interoperability and mutual performance, privacy and security, reduced errors, and improved quality
  • North America held the major share of the market in 2017 due to increased ophthalmic disease burden and healthcare expenditure by public and private firms in this region
  • Asia-Pacific is anticipated to register the highest CAGR during forecast period due to rising prevalence of glaucoma coupled with high demand for an effective diagnostic solution
  • Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. are the major companies in the global ophthalmology PACS market
  • Most of these companies are focusing on technological advancements, M&A, and R&D as part of their business expansion strategies


Please Note: This report will be delivered within 48 hours of ordering.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • EyePACS, LLC
  • ScImage, Inc.
  • Sonomed Escalon
  • Topcon Corporation
  • VersaSuite
  • MORE
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates & Forecast Timeline

Chapter 2 Research Methodology
2.1 Model Details
2.1.1 Regression and variable analysis
2.1.2 Total addressable market (TAM)
2.2 Information Procurement
2.3 List Of Primary Sources
2.3.1 Purchased database:
2.3.2 Internal database
2.4 Primary Interview Breakup
2.4.1 Data for primary interviews, by sources
2.4.2 Data for primary interviews, by region
2.5 List Of Secondary Sources

Chapter 3 Report Objectives
3.1 Objectives

Chapter 4 Executive Summary
4.1 Market Summary

Chapter 5 Market Definitions
5.1 Definitions

Chapter 6 Ophthalmology PACS Market: Industry Outlook
6.1 Market Variable Analysis
6.2 Market Driver Analysis
6.2.1 Rising prevalence of eye diseases
6.2.2 Technological advancements in ophthalmic diagnostic instruments
6.2.3 Government initiatives for increasing awareness related to visual impairment
6.3 Market Restraints Analysis
6.3.1 Lack of trained ophthalmologist in developing nations
6.3.2 High cost of devices in developing in nations
6.4 Business Environment Analysis Tools
6.4.1 Ophthalmic Based Healthcare Preventive Technologies - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
6.4.2 Porter’s Five Forces Analysis

Chapter 7 Regulatory & Political Forces
7.1 Regulatory Landscape

Chapter 8 Competitive & Vendor Landscape
8.1 Market Participation Categorization
8.1.1 Market leader
8.1.2 Innovators
8.2 Strategic Initiatives & Outcome Analysis

Chapter 9 Ophthalmology PACS Market: Type Analysis
9.1 Product Business Analysis
9.2 Standalone PACS
9.2.1 Standalone PACS market estimates and forecasts, 2014 - 2025 (USD Million)
9.3 Integrated PACS
9.3.1 Integrated PACS market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 10 Ophthalmology PACS Market: Delivery Mode Analysis
10.1 Product Business Analysis
10.2 On-Premise System
10.2.1 On-Premise System market estimates and forecasts, 2014 - 2025 (USD Million)
10.3 Cloud-Based System
10.3.1 Cloud-Based System market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 11 Ophthalmology PACS Market: End-use Analysis
11.1 Product Business Analysis
11.2 Hospitals
11.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Million)
11.3 Specialty Clinics
11.3.1 Specialty clinics market estimates and forecasts, 2014 - 2025 (USD Million)
11.4 Others
11.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 12 Ophthalmology PACS Market: Regional Analysis By Type, By Delivery Mode, By End-use
12.1 North America
12.1.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.1.2 U.S.
12.1.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.1.3 Canada
12.1.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2 Europe
12.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.2 Germany
12.2.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.3 U.K.
12.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.4 France
12.2.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.5 Italy
12.2.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.6 Spain
12.2.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3 Asia Pacific
12.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3.2 China
12.3.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3.3 India
12.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4 Latin America
12.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4.2 Mexico
12.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4.3 Brazil
12.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.5 MEA
12.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.5.2 South Africa
12.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 13 Company Profiles
13.1 Key Company Profiled
13.1.1 Carl Zeiss Meditec AG
13.1.1.1 Company Overview
13.1.1.2 Financial Performance
13.1.1.3 Product Benchmarking
13.1.1.4 Strategic Initiatives
13.1.2 Topcon Corporation
13.1.2.1 Company Overview
13.1.2.2 Financial Performance
13.1.2.3 Product Benchmarking
13.1.2.4 Strategic Initiatives
13.1.3 Heidelberg Engineering GmbH
13.1.3.1 Company Overview
13.1.3.2 Product Benchmarking
13.1.3.3 Strategic Initiatives
13.1.4 Sonomed Escalon
13.1.4.1 Company Overview
13.1.4.2 Financial performance
13.1.4.3 Product Benchmarking
13.1.4.4 Strategic Initiatives
13.1.5 Visbion
13.1.5.1 Company Overview
13.1.5.2 Financial Performance
13.1.5.3 Product Benchmarking
13.1.6 EyePACS, LLC
13.1.6.1 Company Overview
13.1.6.2 Product Benchmarking
13.1.6.3 Strategic Initiatives
13.1.7 VersaSuite
13.1.7.1 Company Overview
13.1.7.2 Product Benchmarking
13.1.7.3 Strategic Initiatives
13.1.8 Merge Healthcare Inc. (IBM Watson Health)
13.1.8.1 Company Overview
13.1.8.2 Financial performenrce
13.1.8.3 Product Benchmarking
13.1.8.4 Strategic Initiatives
13.1.9 ScImage, Inc.
13.1.9.1 Company Overview
13.1.9.2 Product Benchmarking
13.1.9.3 Strategic Initiatives

Chapter 14 Recommendations/Conclusion
14.1 Recommendations
14.2 Conclusion
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion
  • EyePACS, LLC
  • VersaSuite
  • Merge Healthcare Inc (IBM Watson Health)
  • ScImage, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751792
Adroll
adroll